Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SODium BICarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC): A Multicentre, Randomised, Double-blind Clinical Trial

NCT05697770 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT05697770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SODium BICarbonate for Metabolic Acidosis in the Intensive Care Unit (SODa-BIC): A Multicentre, Randomised, Double-blind Clinical Trial
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 26, 2023
Completion date
July 31, 2026
Enrollment
500 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic acidosis, shock